世界の抗癌剤におけるパクリタキセル・その類似体市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:128
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、抗癌剤におけるパクリタキセル・その類似体の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗癌剤におけるパクリタキセル・その類似体の種類別市場規模(パクリタキセル、ドセタキセル、リポソームパクリタキセル、タンパク質結合パクリタキセル)、用途別市場規模(卵巣がん、乳がん、子宮頸がん、膵臓がん、非小細胞肺がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Bristol-Myers Squibb、Celgene Corporation、Hospira、Biological E.、Taj Accura、Khandelwal Laboratories、Luye Pharma、Beijing Youcare、Beijing Union、Haiyao、Chuntch、Hengrui Medicine、Sanofi、Qilu Pharma、Shenzhen Main Luck Pharma、Jiangsu Aosaikang Pharma、CSPC Pharmaceutical、Aosaikang Pharm
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:パクリタキセル、ドセタキセル、リポソームパクリタキセル、タンパク質結合パクリタキセル
・用途別分析2016年-2026年:卵巣がん、乳がん、子宮頸がん、膵臓がん、非小細胞肺がん、その他
・抗癌剤におけるパクリタキセル・その類似体の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・抗癌剤におけるパクリタキセル・その類似体のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・抗癌剤におけるパクリタキセル・その類似体のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・抗癌剤におけるパクリタキセル・その類似体の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・抗癌剤におけるパクリタキセル・その類似体の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Paclitaxel and Its Analogue in Anticarcinoma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Paclitaxel and Its Analogue in Anticarcinoma Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Paclitaxel and Its Analogue in Anticarcinoma Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Paclitaxel and Its Analogue in Anticarcinoma Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Paclitaxel
Docetaxel
Liposome Paclitaxel
Protein-bound Paclitaxel

Market segment by Application, can be divided into
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Non-small Cell Lung Cancer
Other

Market segment by players, this report covers
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
CSPC Pharmaceutical
Aosaikang Pharm

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Paclitaxel and Its Analogue in Anticarcinoma Drugs
1.2 Classification of Paclitaxel and Its Analogue in Anticarcinoma Drugs by Type
1.2.1 Overview: Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share by Type in 2020
1.2.3 Paclitaxel
1.2.4 Docetaxel
1.2.5 Liposome Paclitaxel
1.2.6 Protein-bound Paclitaxel
1.3 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market by Application
1.3.1 Overview: Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Cervical Cancer
1.3.5 Pancreatic Cancer
1.3.6 Non-small Cell Lung Cancer
1.3.7 Other
1.4 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size & Forecast
1.5 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast by Region
1.5.1 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Region, (2016-2021)
1.5.3 North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Drivers
1.6.2 Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Restraints
1.6.3 Paclitaxel and Its Analogue in Anticarcinoma Drugs Trends Analysis
2 Company Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.1.4 Bristol-Myers Squibb Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.2 Celgene Corporation
2.2.1 Celgene Corporation Details
2.2.2 Celgene Corporation Major Business
2.2.3 Celgene Corporation Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.2.4 Celgene Corporation Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Celgene Corporation Recent Developments and Future Plans
2.3 Hospira
2.3.1 Hospira Details
2.3.2 Hospira Major Business
2.3.3 Hospira Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.3.4 Hospira Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Hospira Recent Developments and Future Plans
2.4 Biological E.
2.4.1 Biological E. Details
2.4.2 Biological E. Major Business
2.4.3 Biological E. Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.4.4 Biological E. Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Biological E. Recent Developments and Future Plans
2.5 Taj Accura
2.5.1 Taj Accura Details
2.5.2 Taj Accura Major Business
2.5.3 Taj Accura Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.5.4 Taj Accura Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Taj Accura Recent Developments and Future Plans
2.6 Khandelwal Laboratories
2.6.1 Khandelwal Laboratories Details
2.6.2 Khandelwal Laboratories Major Business
2.6.3 Khandelwal Laboratories Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.6.4 Khandelwal Laboratories Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Khandelwal Laboratories Recent Developments and Future Plans
2.7 Luye Pharma
2.7.1 Luye Pharma Details
2.7.2 Luye Pharma Major Business
2.7.3 Luye Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.7.4 Luye Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Luye Pharma Recent Developments and Future Plans
2.8 Beijing Youcare
2.8.1 Beijing Youcare Details
2.8.2 Beijing Youcare Major Business
2.8.3 Beijing Youcare Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.8.4 Beijing Youcare Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Beijing Youcare Recent Developments and Future Plans
2.9 Beijing Union
2.9.1 Beijing Union Details
2.9.2 Beijing Union Major Business
2.9.3 Beijing Union Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.9.4 Beijing Union Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Beijing Union Recent Developments and Future Plans
2.10 Haiyao
2.10.1 Haiyao Details
2.10.2 Haiyao Major Business
2.10.3 Haiyao Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.10.4 Haiyao Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Haiyao Recent Developments and Future Plans
2.11 Chuntch
2.11.1 Chuntch Details
2.11.2 Chuntch Major Business
2.11.3 Chuntch Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.11.4 Chuntch Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Chuntch Recent Developments and Future Plans
2.12 Hengrui Medicine
2.12.1 Hengrui Medicine Details
2.12.2 Hengrui Medicine Major Business
2.12.3 Hengrui Medicine Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.12.4 Hengrui Medicine Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Hengrui Medicine Recent Developments and Future Plans
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.13.4 Sanofi Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Sanofi Recent Developments and Future Plans
2.14 Qilu Pharma
2.14.1 Qilu Pharma Details
2.14.2 Qilu Pharma Major Business
2.14.3 Qilu Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.14.4 Qilu Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Qilu Pharma Recent Developments and Future Plans
2.15 Shenzhen Main Luck Pharma
2.15.1 Shenzhen Main Luck Pharma Details
2.15.2 Shenzhen Main Luck Pharma Major Business
2.15.3 Shenzhen Main Luck Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.15.4 Shenzhen Main Luck Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Shenzhen Main Luck Pharma Recent Developments and Future Plans
2.16 Jiangsu Aosaikang Pharma
2.16.1 Jiangsu Aosaikang Pharma Details
2.16.2 Jiangsu Aosaikang Pharma Major Business
2.16.3 Jiangsu Aosaikang Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.16.4 Jiangsu Aosaikang Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Jiangsu Aosaikang Pharma Recent Developments and Future Plans
2.17 CSPC Pharmaceutical
2.17.1 CSPC Pharmaceutical Details
2.17.2 CSPC Pharmaceutical Major Business
2.17.3 CSPC Pharmaceutical Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.17.4 CSPC Pharmaceutical Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 CSPC Pharmaceutical Recent Developments and Future Plans
2.18 Aosaikang Pharm
2.18.1 Aosaikang Pharm Details
2.18.2 Aosaikang Pharm Major Business
2.18.3 Aosaikang Pharm Paclitaxel and Its Analogue in Anticarcinoma Drugs Product and Solutions
2.18.4 Aosaikang Pharm Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Aosaikang Pharm Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Paclitaxel and Its Analogue in Anticarcinoma Drugs Players Market Share
3.2.2 Top 10 Paclitaxel and Its Analogue in Anticarcinoma Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Paclitaxel and Its Analogue in Anticarcinoma Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Market Share by Application (2016-2021)
5.2 Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Type (2016-2026)
6.2 North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Application (2016-2026)
6.3 North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Country
6.3.1 North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Country (2016-2026)
6.3.2 United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Type (2016-2026)
7.2 Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Application (2016-2026)
7.3 Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Country
7.3.1 Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Country (2016-2026)
7.3.2 Germany Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
7.3.3 France Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Region
8.3.1 Asia-Pacific Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Region (2016-2026)
8.3.2 China Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
8.3.5 India Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Type (2016-2026)
9.2 South America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Application (2016-2026)
9.3 South America Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Country
9.3.1 South America Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Country
10.3.1 Middle East & Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗癌剤におけるパクリタキセル・その類似体市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。